These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 207786)

  • 1. Salivary neutralizing activity against herpes simplex virus type 1.
    Gyselink R; Coles D; Ash RJ; Fritz ME
    J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus microneutralization: a simplification of the test.
    Stalder H; Oxman MN; Herrmann KL
    J Infect Dis; 1975 Apr; 131(4):423-30. PubMed ID: 163870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.
    Doerr HW; Gross G; Schmitz H
    Med Microbiol Immunol; 1976 Dec; 162(3-4):183-92. PubMed ID: 187917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of herpes simplex virus type 1 (HSV-1) plaque enlargement by neutralizing sera.
    Mannini-Palenzona A; Costanzo F; Foà-Tomasi L; Negosanti M; Lanzoni A
    Microbiologica; 1989 Jul; 12(3):231-40. PubMed ID: 2476650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of herpes simplex virus in children by detection of specific antibodies in saliva.
    Spicher VM; Bouvier P; Schlegel-Haueter SE; Morabia A; Siegrist CA
    Pediatr Infect Dis J; 2001 Mar; 20(3):265-72. PubMed ID: 11303828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary defense factors in herpes simplex virus infection.
    Välimaa H; Waris M; Hukkanen V; Blankenvoorde MF; Nieuw Amerongen AV; Tenovuo J
    J Dent Res; 2002 Jun; 81(6):416-21. PubMed ID: 12097435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
    Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
    Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Aug; 84(8):622-9. PubMed ID: 196613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence and neutralizing antibodies to herpes simplex virus in the cerebrospinal fluid of patients with central nervous system diseases.
    Leventon-Kriss S; Rannon L; Joffe R
    Isr J Med Sci; 1976 Jun; 12(6):553-9. PubMed ID: 182656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody.
    Ratner JJ; Sanford BA; Smith KO
    J Clin Microbiol; 1979 Oct; 10(4):415-8. PubMed ID: 231047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A seroepidemiological survey of herpes simplex virus in pregnant women by microneutralization test and ELISA (author's transl)].
    Hayashi Y; Mori R; Minamishima Y; Hamada T; Tateyama H; Sugawara H; Yamamoto S
    Kansenshogaku Zasshi; 1982 Feb; 56(2):118-25. PubMed ID: 6286805
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutralizing antibody to herpes simplex virus by a novel neutralization method with peroxidase-labelled complement Clq.
    Taguchi F; Kawasaki T; Matsuzaki T; Lee SM
    J Virol Methods; 1991 May; 32(2-3):157-62. PubMed ID: 1651947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory IgA against herpes simplex virus in cervical secretions.
    Persson E; Eneroth P; Jeansson S
    Genitourin Med; 1988 Dec; 64(6):373-7. PubMed ID: 2852157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies of the IgG and IgM classes to herpes simplex virus type 1 in cerebrospinal fluid and serum from four patients with herpes encephalitis.
    Rapicetta M; Morace G; Alema G; Mancini G
    Microbiologica; 1984 Jul; 7(3):273-7. PubMed ID: 6094987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme immunoassay for measurement of antibodies to herpes simplex virus infection: comparison with complement fixation, immunofluorescent-antibody, and neutralization techniques.
    Denoyel GA; Gaspar A; Nouyrigat C
    J Clin Microbiol; 1980 Feb; 11(2):114-9. PubMed ID: 6244329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies against herpes simplex virus in maternal and umbilical cord serum.
    Ishiguro T; Ozaki Y
    Acta Obstet Gynecol Scand; 1979; 58(4):413-4. PubMed ID: 230696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
    Jankowski MA; Petersen EE; Böcker JF
    Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serologic examination for childhood herpes simplex virus infection].
    Tang JP; Yang YJ; Zhang D; Li LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):476-8. PubMed ID: 17178039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.